Seattle Genetics to Webcast Virtual Fireside Chat at Needham Healthcare Conference
Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will participate in a fireside chat at the Needham Healthcare Conference on Tuesday, April 14, 2020 at 12:00 p.m. Eastern Time. The conference will be held in a virtual meeting format. The presentation will be webcast live and available for replay from Seattle Genetics' website at www.seattlegenetics.com in the Investors section.
About Seattle Genetics
Seattle Genetics, Inc. is a global biotechnology company that discovers, develops and commercializes transformative medicines targeting cancer to make a meaningful difference in people's lives. ADCETRIS® (brentuximab vedotin) and PADCEVTM (enfortumab vedotin-ejfv) use the company's industry-leading antibody-drug conjugate (ADC) technology. ADCETRIS is approved in certain CD30-expressing lymphomas, and PADCEV is approved in certain metastatic urothelial cancers. In addition, investigational agent tucatinib, a small molecule tyrosine kinase inhibitor, is in late-stage development for HER2-positive metastatic breast cancer and in clinical development for metastatic colorectal cancer. The company is headquartered in Bothell, Washington, and has offices in California, Switzerland and the European Union. For more information on our robust pipeline, visit www.seattlegenetics.com and follow @SeattleGenetics on Twitter.
Materialise NV , a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2024.
Highlights ? First Quarter 2024
Total...
Merck , known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2024.
"Merck has begun 2024 with continuing momentum in our business. We are harnessing the power of innovation to advance our...
Strategic Education, Inc. (Strategic Education) today announced financial results for the period ended March 31, 2024.
"As we begin a new year, we are pleased with strength across our business and proud of the organization's ongoing commitment to...
Sage Therapeutics, Inc. , a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the first quarter ended March 31, 2024.
"The launch of ZURZUVAE is off to...
The time it takes to deploy new value-added services for broadband customers has been drastically reduced from months to weeks opening the door to delivering an app-store-like experience via broadband routers.
Value-added services like...
Congruent Solutions, a leading provider of Software-as-a-Service (SaaS) and outsourced plan administration services to the retirement industry in the U.S., today announced the appointment of Mahesh Natarajan as its Chief Revenue Officer.
Natarajan...
